|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2000-6-7
|
|
pubmed:abstractText |
To investigate the activity and toxicity of gemcitabine as a single agent in patients with advanced non-small-cell lung cancer (NSCLC) after recurrence or failure of previous treatment with a platinum-containing regimen.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:CalandriCC,
pubmed-author:CrinòLL,
pubmed-author:De MarinisFF,
pubmed-author:Della GiuliaMM,
pubmed-author:GridelliCC,
pubmed-author:MosconiA MAM,
pubmed-author:NosedaMM,
pubmed-author:NovelloSS,
pubmed-author:RinaldiMM,
pubmed-author:RossiAA,
pubmed-author:ScagliottiGG,
pubmed-author:SelvaggiGG,
pubmed-author:TonatoMM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2081-5
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10561261-Adult,
pubmed-meshheading:10561261-Aged,
pubmed-meshheading:10561261-Antimetabolites, Antineoplastic,
pubmed-meshheading:10561261-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:10561261-Deoxycytidine,
pubmed-meshheading:10561261-Female,
pubmed-meshheading:10561261-Humans,
pubmed-meshheading:10561261-Italy,
pubmed-meshheading:10561261-Lung Neoplasms,
pubmed-meshheading:10561261-Male,
pubmed-meshheading:10561261-Middle Aged,
pubmed-meshheading:10561261-Salvage Therapy,
pubmed-meshheading:10561261-Survival Analysis
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Gemcitabine as second-line treatment for advanced non-small-cell lung cancer: A phase II trial.
|
|
pubmed:affiliation |
Medical Oncology Division, Policlinico Hospital, Perugia, Italy. oncmedpg@krenet.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
